Acute diarrhoea in dogs: metronidazole vs placebo — MAYBE (weak evidence)

In dogs with acute diarrhoea, does metronidazole shorten time to resolution vs placebo?

Shelf #163 · gate-verified and displayed under the developer's blinded-trial rule

MAYBE (weak evidence): Two randomised, double-blinded, placebo-controlled trials point in different directions. Langlois 2020 (31 dogs) found diarrhoea resolved about 1.5 days sooner on metronidazole (2.1 vs 3.6 days, P = .04); Shmalberg 2019 (60 dogs) found essentially no difference (4.6 vs 4.8 days to acceptable faecal consistency, p = 0.17). In every arm of both trials the diarrhoea settled within days, treated or not — so the most a clinician can honestly expect is a possible shortening of around a day, on conflicting evidence from two small trials. Drafted Nov 10, 2026 (VetMed build, topic #163); all figures from abstracts fetched and verified at drafting.

Langlois 2020: metronidazole shortened diarrhoea by about 1.5 days in 31 dogs (2.1 vs 3.6 days, P = .04)

Randomised, double-blinded, placebo-controlled clinical trial

Who: Dogs: 31 dogs with acute nonspecific diarrhoea in which routine faecal diagnostic testing determined no cause — 14 test-population dogs and 17 controls as enrolled — randomly assigned to metronidazole (10–15 mg/kg PO q12h for 7 days) or placebo; owners kept medication and faecal scoring logs and faecal testing was repeated on day 7.

Result: Mean ± SD time to resolution of diarrhoea was 2.1 ± 1.6 days on metronidazole vs 3.6 ± 2.1 days on placebo (P = .04). Persistent Clostridium perfringens carriage at day 7 was also less frequent on metronidazole: 3 of 13 test dogs (23.1%) vs 11 of 14 controls (78.6%) (P = .007).

Watch out: A small single trial with a borderline P value; the authors themselves caution that most dogs resolve within several days regardless of treatment and that the benefits and risks of routine metronidazole use need further study. The larger Shmalberg 2019 trial below did not reproduce the clinical benefit.

Langlois DK, Koenigshof AM, Mani R. Metronidazole treatment of acute diarrhea in dogs: A randomized double blinded placebo-controlled clinical trial. J Vet Intern Med. 2020;34(1):98-104. PMID: 31742807. Registry ID: none in the record. MeSH: Acute Disease · Animals · Diarrhea · Dog Diseases · Dogs · Double-Blind Method · Feces · Female · Male · Metronidazole

Shmalberg 2019: no significant difference — metronidazole 4.6 days, placebo 4.8 days, probiotic 3.5 days to acceptable faecal consistency (60 dogs)

Randomised, double-blinded, placebo-controlled clinical trial (three arms)

Who: Dogs: 60 dogs presenting with acute diarrhoea and without concurrent comorbidities, randomised to a probiotic combination, oral metronidazole, or placebo; time to resolution of diarrhoeal signs assessed with owner surveys and faecal scoring charts.

Result: Dogs achieved acceptable faecal consistency after 3.5 ± 2.2 days on probiotic, 4.6 ± 2.4 days on metronidazole, and 4.8 ± 2.9 days on placebo; no statistically significant differences were identified between treatment groups (p = 0.17). The authors conclude the findings failed to provide evidence for the common use of metronidazole in this cohort.

Watch out: Three arms means roughly 20 dogs per arm — still small, but larger than Langlois 2020, and it found no metronidazole effect. This record carries no MeSH terms and its publication-type indexing is anomalous; the design words on this card come from the paper's own title and abstract.

Shmalberg J, Montalbano C, Morelli G et al. A Randomized Double Blinded Placebo-Controlled Clinical Trial of a Probiotic or Metronidazole for Acute Canine Diarrhea. Front Vet Sci. 2019;6:163. PMID: 31275948. Registry ID: none in the record. MeSH: none in the record

Synthesis: two small placebo-controlled trials disagree — at most a possible ~1-day shortening

Synthesis

Who: Synthesis of the cards above: Langlois 2020 (randomised double-blinded placebo-controlled, 31 dogs) and Shmalberg 2019 (randomised double-blinded placebo-controlled, three arms, 60 dogs).

Result: Read together, the trials bracket the truth: one found a statistically significant ~1.5-day shortening, the larger one found a 0.2-day difference that was nowhere near significant. Both agree on the background fact that matters most for the consultation: acute nonspecific diarrhoea in dogs resolves within several days with or without metronidazole. The C. perfringens clearance seen in Langlois is a culture finding, not a clinical outcome, and Shmalberg's probiotic arm (3.5 days) is a separate shelf's question (topic #164).

Watch out: Neither trial was large, doses and populations differed (Langlois used 10–15 mg/kg q12h for 7 days in diarrhoea of undetermined cause; Shmalberg enrolled uncomplicated presentations without comorbidities), and antibiotic-resistance and microbiome costs of routine metronidazole are not measured in either trial's clinical endpoint.

Synthesis of Langlois DK et al. PMID: 31742807; Shmalberg J et al. PMID: 31275948. Registry IDs as on the individual cards.

Back to the library index · VetMed home

VetMed is an educational resource, not veterinary advice.